My ePortfolio Register   
Filter results by:

Showing: Treatments / Targeted molecules

Research: Evidence on the cost of breast cancer drugs is required for rational decision making

Abstract | Full Article | PDF Published: 16 Apr 2018 / https://doi.org/10.3332/ecancer.2018.825

Conference Report: Highlights from the 10th Breast, Gynaecological and Immunotherapy International Cancer Conference (BGICC), 18–19 January 2018, Cairo, Egypt

Abstract | Full Article | PDF Published: 22 Mar 2018 / https://doi.org/10.3332/ecancer.2018.820

Review: Cystic brain metastases in ALK-rearranged non-small cell lung cancer

Abstract | Full Article | PDF Published: 14 Mar 2018 / https://doi.org/10.3332/ecancer.2018.818

Conference Report: Highlights from the WIN 2017 Symposium, 26–27 June 2017, Paris, France: ‘Expediting Global Innovation in Precision Cancer Medicine’

Abstract | Full Article | PDF Published: 27 Sep 2017 / https://doi.org/10.3332/ecancer.2017.770

Conference Report: Highlights from the ecancer Future Horizons in Lung Cancer conference, 1–2 September 2016: Focusing on the future of treatment for NSCLC and SCLC

Abstract | Full Article | PDF Published: 23 Mar 2017 / https://doi.org/10.3332/ecancer.2017.729

Research: Circulating and tissue biomarkers in early-stage non-small cell lung cancer

Abstract | Full Article | PDF Published: 31 Jan 2017 / https://doi.org/10.3332/ecancer.2017.717

Review: An Australasian perspective on the curative treatment of patients with pancreatic cancer, supportive care, and future directions for management

Abstract | Full Article | PDF Published: 07 Dec 2016 / https://doi.org/10.3332/ecancer.2016.700

Special Issue: Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

Abstract | Full Article | PDF Published: 28 Oct 2016 / https://doi.org/10.3332/ecancer.2016.684

Conference Report: Highlights from the 2016 WIN Symposium, 27–29 June 2016, Paris: personalised therapy beyond next-generation sequencing

Abstract | Full Article | PDF Published: 24 Aug 2016 / https://doi.org/10.3332/ecancer.2016.669

Review: Role of nanotechnology and gene delivery systems in TRAIL based therapies

Abstract | Full Article | PDF Published: 01 Aug 2016 / https://doi.org/10.3332/ecancer.2016.660



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence